 | | | | The U.S. drug regulator on Tuesday authorized Bavarian Nordic's Jynneos vaccine for emergency use through intradermal injection in individuals aged 18 years and older who are determined to be at high risk of monkeypox infection. | | | | | | The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia, were contaminated with a possible carcinogen. | | | | | | Britain will run out of monkeypox vaccines in about two to three weeks as the country has little more than 8,300 doses of vaccine left, the Financial Times reported on Tuesday. | | | | | | U.S. President Joe Biden continues to test negative for COVID-19 but is suffering its lingering effects, the White House press office said on Tuesday, after he coughed repeatedly through a speech on the South Lawn. | | | | | | Few U.S. adults diagnosed with hepatitis C virus infections receive timely treatment with antiviral drugs, the U.S. Centers for Disease Control and Prevention said on Tuesday. | | | | | | Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said. | | | | | | Pfizer Inc on Monday agreed to pay $5.4 billion in cash for sickle cell disease drugmaker Global Blood Therapeutics , as it looks to capitalize on a surge in revenue from its COVID-19 vaccine and treatment. | | | | | | The U.S. government will buy Siga Technologies Inc's $26-million worth of intravenous formulation of antiviral drug Tpoxx, the company said on Tuesday, as the country fights an outbreak of monkeypox cases. | | | | | | Global health aid agency Unitaid is donating 220 specialised portable breathing devices to Ukraine that can help save lives of premature babies even in frontline hospitals where there is no electrical power. | | | | | | U.S. vaccine maker Novavax slumped nearly 31% on Tuesday as falling demand for its COVID-19 shot from low- and middle-income nations led the company to cut its annual revenue expectation by half. | | | | | |
